Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.
Stay informed with our financial updates, stocks, bonds, commodities. Get global & political insights. Follow us & enable notifications for the latest updates.
Morgan Stanley on US Elections and Asia’s Outlook Tariffs are expected to be a key issue for Asia. If implemented, they could create downside risks […]
There are rumors circulating that Tesla is gearing up for a significant round of layoffs – as reported by Electrek. Tesla has informed Gigafactory Texas […]
SEBI Chair is expected to release a discussion paper today or tomorrow outlining measures to address derivatives trading. SEBI will soon require brokers to display […]